Skip to main content

Abbott Laboratories balance sheet

  • ABT · NYSE
  • Pharmaceuticals
  • Health Care Equipment
  • S&P 500
$108.52+1.18%Close 13 Nov 2026 · Market value $187.6B

At the end of fiscal 2025 (the year to 31 Dec 2025), Abbott Laboratories reported total assets of $86.71B, $8.52B in cash and equivalents, $14.14B of total debt; shareholders' equity was $52.13B.

From Abbott Laboratories's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

Abbott Laboratories balance sheet, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$2.46B$4.11B$8.81B$3.65B$6.81B$10.80B$3.48B$4.06B$5.00B$18.62B$9.41B$3.84B$3.86B$6.84B$9.80B$9.88B$6.90B$7.62B$8.52B
Short-term investments$364.4M$967.6M$1.12B$1.80B$1.28B$4.37B$4.62B$397.0M$1.12B$155.0M$203.0M$242.0M$280.0M$310.0M$450.0M$288.0M$383.0M$351.0M$417.0M
Cash and short-term investments$2.82B$5.08B$9.93B$5.45B$8.10B$15.17B$8.10B$4.46B$6.13B$18.77B$9.61B$4.09B$4.14B$7.15B$10.25B$10.17B$7.28B$7.97B$8.94B
Accounts receivable$4.95B$5.47B$6.54B$7.18B$7.68B$7.61B$3.99B$3.59B$3.42B$3.25B$5.25B$5.18B$5.42B$6.41B$6.49B$6.22B$6.57B$6.92B$7.93B
Inventory$2.95B$2.78B$3.26B$3.19B$3.28B$3.79B$2.69B$2.64B$2.60B$2.43B$3.60B$3.80B$4.32B$5.01B$5.16B$6.17B$6.57B$6.19B$6.49B
Current assets$14.04B$17.04B$23.31B$22.32B$23.77B$31.32B$19.25B$13.56B$14.15B$26.78B$20.15B$14.63B$15.67B$20.44B$24.24B$25.22B$22.67B$23.66B$26.00B
Property, plant and equipment$7.52B$7.22B$7.62B$7.97B$7.87B$8.06B$5.91B$5.93B$5.73B$5.71B$7.61B$7.56B$8.04B$9.03B$8.96B$9.16B$10.15B$10.66B$11.82B
Goodwill$10.13B$9.99B$13.20B$15.93B$15.71B$15.77B$9.77B$10.07B$9.64B$7.68B$24.02B$23.25B$23.20B$23.74B$23.23B$22.80B$23.68B$23.11B$24.04B
Acquired intangibles$5.72B$5.15B$6.29B$12.15B$9.99B$8.59B$5.74B$6.20B$5.56B$4.54B$21.47B$18.94B$17.02B$14.78B$12.74B$10.45B$8.81B$6.65B$5.53B
Long-term investments$1.13B$1.07B$1.13B$302.0M$378.2M$274.0M$119.0M$229.0M$4.04B$2.95B$883.0M$897.0M$883.0M$821.0M$816.0M$766.0M$799.0M$886.0M$918.0M
Total assets$39.71B$42.42B$52.58B$60.57B$60.28B$67.23B$42.95B$41.21B$41.25B$52.67B$76.25B$67.17B$67.89B$72.55B$75.20B$74.44B$73.21B$81.41B$86.71B
Short-term borrowings$1.83B$1.69B$4.98B$4.35B$2.35B$2.08B$3.16B$4.38B$3.13B$1.32B$206.0M$200.0M$201.0M$213.0M$0.00————
Long-term debt · current portion$898.6M$1.04B$211.2M$2.04B$1.03B$309.0M$9.00M$55.00M$3.00M$3.00M$508.0M$7.00M$1.28B$7.00M$754.0M$2.25B$1.08B$1.50B$3.03B
Current liabilities$9.10B$11.59B$13.05B$17.26B$15.48B$13.28B$9.51B$10.47B$9.19B$6.66B$8.91B$9.01B$10.86B$11.91B$13.11B$15.49B$13.84B$14.16B$16.50B
Long-term debt · non-current$9.49B$8.71B$11.27B$12.52B$12.04B$18.09B$3.39B$3.39B$5.87B$20.68B$27.21B$19.36B$16.66B$18.53B$17.30B$14.52B$13.60B$12.63B$9.90B
Operating lease liability————————————$960.0M$1.14B$1.20B$1.17B$1.19B$1.15B$1.21B
Total liabilities$21.89B$24.90B$29.39B$37.81B$35.75B$40.42B$17.69B$19.57B$19.92B$31.95B$45.15B$36.45B$36.59B$39.55B$39.17B$37.53B$34.39B$33.51B$33.94B
Retained earnings$10.81B$13.83B$17.34B$19.22B$20.91B$24.15B$21.98B$22.87B$25.76B$25.57B$23.98B$24.56B$25.85B$27.63B$31.53B$35.26B$37.55B$47.26B$49.78B
Minority interest$45.41M$39.14M$43.10M$88.33M$86.31M$92.00M$96.00M$113.0M$115.0M$179.0M$201.0M$198.0M$213.0M$219.0M$222.0M$219.0M$224.0M$237.0M$641.0M
Shareholders' equity$17.78B$17.48B$23.14B$22.68B$24.44B$26.72B$25.17B$21.53B$21.21B$20.54B$30.90B$30.52B$31.09B$32.78B$35.80B$36.69B$38.60B$47.66B$52.13B
Total liabilities and equity$39.71B$42.42B$52.58B$60.57B$60.28B$67.23B$42.95B$41.21B$41.25B$52.67B$76.25B$67.17B$67.89B$72.55B$75.20B$74.44B$73.21B$81.41B$86.71B
Total debt$12.21B$11.45B$16.46B$18.92B$15.41B$20.48B$6.56B$7.83B$9.00B$22.01B$27.92B$19.57B$19.10B$19.89B$19.25B$17.95B$15.87B$15.28B$14.14B
Net debt$9.39B$6.37B$6.52B$13.47B$7.32B$5.30B−$1.54B$3.37B$2.88B$3.23B$18.31B$15.48B$14.96B$12.74B$9.00B$7.78B$8.59B$7.31B$5.20B
Net working capital$2.48B$1.34B$1.46B$1.41B$1.48B$7.24B$6.26B−$974.0M−$32.00M$1.50B$1.83B$1.78B$944.0M$1.70B$1.33B−$147.0M$1.93B$1.88B$978.0M
Shares outstanding · period end——1.6B1.5B1.6B1.6B1.5B1.5B1.5B1.7B1.7B1.8B1.8B1.8B1.8B1.7B1.7B1.7B1.7B

Quarterly

Abbott Laboratories balance sheet, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Cash and equivalents$6.90B$6.28B$6.99B$7.56B$7.62B$6.53B$6.95B$7.51B$8.52B$6.80B$5.10B$4.05B
Short-term investments$383.0M$367.0M$232.0M$230.0M$351.0M$312.0M$331.0M$222.0M$417.0M$492.0M$499.0M$246.0M
Cash and short-term investments$7.28B$6.65B$7.22B$7.79B$7.97B$6.84B$7.28B$7.73B$8.94B$7.29B$5.60B$4.30B
Accounts receivable$6.57B$6.61B$6.85B$7.05B$6.92B$7.33B$7.97B$8.14B$7.93B$8.21B$8.60B$9.03B
Inventory$6.57B$6.83B$6.81B$6.81B$6.19B$6.64B$6.95B$6.71B$6.49B$6.99B$7.32B$7.34B
Current assets$22.67B$22.38B$23.12B$23.80B$23.66B$23.15B$24.47B$24.84B$26.00B$25.51B$24.52B$23.50B
Property, plant and equipment$10.15B$10.11B$10.23B$10.62B$10.66B$10.93B$11.39B$11.50B$11.82B$12.38B$12.81B$12.88B
Goodwill$23.68B$23.38B$23.31B$23.66B$23.11B$23.36B$23.95B$23.97B$24.04B$35.22B$35.24B$32.64B
Acquired intangibles$8.81B$8.30B$7.83B$7.35B$6.65B$6.26B$5.92B$5.60B$5.53B$17.88B$17.21B$19.59B
Long-term investments$799.0M$818.0M$877.0M$912.0M$886.0M$907.0M$958.0M$951.0M$918.0M$1.09B$1.11B$1.10B
Total assets$73.21B$72.47B$73.02B$74.36B$81.41B$81.45B$84.00B$84.18B$86.71B$110.4B$109.2B$108.2B
Long-term debt · current portion$1.08B$2.01B$1.61B$2.15B$1.50B$506.0M$507.0M$1.34B$3.03B$4.41B$3.00B$1.71B
Current liabilities$13.84B$14.02B$13.76B$14.90B$14.16B$13.00B$13.44B$14.58B$16.50B$18.38B$17.81B$16.15B
Long-term debt · non-current$13.60B$12.58B$13.14B$12.82B$12.63B$12.74B$12.93B$11.60B$9.90B$29.64B$29.60B$29.45B
Operating lease liability$1.19B———$1.15B———$1.21B———
Total liabilities$34.39B$33.42B$33.46B$34.33B$33.51B$32.38B$33.17B$32.92B$33.94B$57.73B$57.45B$56.62B
Retained earnings$37.55B$38.01B$38.35B$39.06B$47.26B$47.72B$48.47B$49.10B$49.78B$49.96B$49.79B$49.64B
Minority interest$224.0M$233.0M$242.0M$232.0M$237.0M$253.0M$264.0M$310.0M$641.0M$640.0M$652.0M$596.0M
Shareholders' equity$38.60B$38.81B$39.32B$39.80B$47.66B$48.81B$50.56B$50.95B$52.13B$52.06B$51.11B$51.03B
Total liabilities and equity$73.21B$72.47B$73.02B$74.36B$81.41B$81.45B$84.00B$84.18B$86.71B$110.4B$109.2B$108.2B
Total debt$15.87B$14.59B$14.75B$14.98B$15.28B$13.24B$13.44B$12.94B$14.14B$34.05B$32.61B$31.16B
Net debt$8.59B$7.93B$7.54B$7.19B$7.31B$6.40B$6.16B$5.21B$5.20B$26.75B$27.00B$26.86B
Net working capital$1.93B$2.07B$2.37B$1.34B$1.88B$3.62B$4.08B$2.75B$978.0M$328.0M$1.60B$3.29B
Shares outstanding · period end1.7B1.7B1.7B1.7B1.7B1.7B1.7B1.7B1.7B1.7B1.7B1.7B

The main figures as JSON and plain text. See data and methodology.

ABT in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.